Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and Brucella Infection

vidarabine has been researched along with Brucella Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, JG1
Brion, JP; Epaulard, O; Garin-Bastuji, B; Gressin, R; Maurin, M; Meneses, A; Pavese, P; Stahl, JP1

Other Studies

2 other study(ies) available for vidarabine and Brucella Infection

ArticleYear
Fludarabine is effective in treating refractory hemophagocytic lymphohistiocytosis with brucellosis.
    International journal of rheumatic diseases, 2017, Volume: 20, Issue:12

    Topics: Anti-Bacterial Agents; Brucellosis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Treatment Outcome; Vidarabine

2017
[Brucella bacteremia reactivation 70 years after the primary infection].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:4

    Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Brucella melitensis; Brucellosis; Combined Modality Therapy; Cyclophosphamide; Doxycycline; Drug Therapy, Combination; Female; France; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Lymphoma, Non-Hodgkin; Recurrence; Rifampin; Rituximab; Spain; Time Factors; Vidarabine

2010